Lerociclib HCl (G1T38) is a novel, selective,differentiated oral CDK4/6 inhibitor with biochemical IC50 values of 1 nM, 2 nM and 28 μnM for CDK4, CDK6 and CDK9 respectively. Lerociclib (G1T38) with potential use in combination with other targeted therapies in certain types of breast and lung cancer.
Lerociclib (Free base) , Bulk in stock, contact us by email for the Bulk quotation.
For research use only. We do not sell to patients.